Did you know?

According to . 4 Wall Street analysts that have issued a 1 year CMPS price target, the average CMPS price target is $57.25, with the highest CMPS stock price forecast at $120.00 and the lowest CMPS stock price forecast at $21.00. What this means: InvestorsObserver gives Compass Therapeutics Inc. (CMPX) an overall rank of 34, which is below average. Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.See CAPITAL POWER CORPORATION stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 44.85 0.00 0.00%. The 10 analysts offering 1 year price forecasts for CPX have a max estimate of — and a min estimate of —.Get The Latest TVE Stock Analysis, Price Target, Dividend Info, and Headlines at MarketBeat. ... View our TVE earnings forecast. How were Tamarack Valley Energy's earnings last quarter? Tamarack Valley Energy Ltd (TSE:TVE) issued its quarterly earnings data on Thursday, October, 26th. The company reported $0.02 EPS …The development of new drugs generally has a high failure rate, and such failures may negatively impact the stock price of the company developing the failed ...Greenlane Holdings, Inc. (NASDAQ:GNLN) released its earnings results on Monday, November, 15th. The company reported ($46.00) earnings per share for the quarter, missing the consensus estimate of ($14.00) by $32.00. The company had revenue of $41.31 million for the quarter, compared to analyst estimates of $40.31 million.The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 78.95% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -469.95% off the target high and -314.51% off the low.The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 82.01% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -566.67% off the target high and -384.85% off the low.Compx International Inc: A High-Performing Stock with a GF Score of 93. GF Score analysis. Find the latest CompX International Inc. (CIX) stock quote, history, news and other vital information to ... Jul 11, 2023 · CMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023. The average Cabaletta Bio stock price prediction forecasts a potential upside of 75.22% from the current CABA share price of $18.67. What is CABA's forecast return on ...The stock has increased 17.9% in price over the past month and closed Friday’s trading session at $3.03. Each of the four Wall Street analysts that rated ELEV rated it Buy. The 12-month median price target of $11.50 indicates a 279.5% potential upside. The price targets range from a low of $11.00 to a high of $12.00.The value each CMPX share was expected to gain vs. the value that each CMPX share actually gained. Compass Therapeutics ( CMPX) reported Q2 2023 earnings per share (EPS) of -$0.09, missing estimates of -$0.08 by 9.30%. In the same quarter last year, Compass Therapeutics 's earnings per share (EPS) was -$0.08. Compass Therapeutics is expected to ...Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Safe & Green Development Corp. $1.95. -0.70. -26.42%. COMP | A complete NASDAQ Composite Index index overview by MarketWatch. View stock market news, stock market data and trading information.Nov 15, 2023 · The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecasts CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.Complete Compass Therapeutics Inc. stock information by Barron's. View real-time CMPX stock price and news, along with industry-best analysis.View NASDAQ COMPOSITE COMPX investment & stock information. Get the latest NASDAQ COMPOSITE COMPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Greenlane Holdings, Inc. (NASDAQ:GNLN) released its earningsAs per the forecast and algorithmic analysis, CMPX st Source: YCharts. Management said during the company's 2022 investor day in June last year that it expects long-term annual revenue growth of 20%. Assuming AMD's top line grows at an annual pace of ... From AI system, total return is 2366.52% from 4098 fo Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Stock analysis for Compass Therapeutics Inc (CMPX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. CMPX Stock Forecast Chart 2w 1m 3m 9m 1y 1.3 1.4 1.5 1.

Complix' Alphabody™ Protein Therapeutics Demonstrate Activity against both Undruggable Extracellular and Intracellular Disease TargetsWeather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.Find the latest Immunovant, Inc. (IMVT) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 23, 2022 · Stock Screener; ETF Screener; Comparisons; Explore Alpha Picks ... Compass Therapeutics (CMPX) Investor Presentation - Slideshow. Nov. 23, 2022 6:22 AM ET Compass Therapeutics, Inc. (CMPX) SA ...

Top Analysts Based on 1 analyst offering 12 month price targets for Compass Therapeutics Inc. Min Forecast $10.00 +528.93% Avg Forecast $10.00 +528.93% Max Forecast …Find the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range investment rating…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Jun 15, 2023 · Learn more about Compass Therape. Possible cause: Source: YCharts. Management said during the company's 2022 investor day in .